Invited Commentary
Commentary on “Prevalence of Osteopenia and Osteoporosis in Patients with Noncystic Fibrosis Bronchiectasis”
Abstract
In this issue of the Southern Medical Journal, Diehl and Johnson’s small retrospective study looks specifically at adults with noncystic fibrosis bronchiectasis (NCFB) and considers possible contributing factors such as the use of proton pump inhibitors (PPIs) and inhaled corticosteroids (ICSs).1 It is unique in that previous studies investigated patients with either cystic fibrosis or NCFB.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.